SciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. KBH
2. PATH
3. SPY
4. USO
5. AZO
6. RCL
7. PLTR
8. ONON
9. QQQ
10. PRGS

Go back to SciSparc: NeuroThera-Clearmind Collaboration Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
(NASDAQ: CMND) Delayed: 0.82 +0.04 (5.13%)
Previous Close $0.78    52 Week High $ 
Open $0.80    52 Week Low $ 
Day High $0.83    P/E N/A 
Day Low $0.78    EPS $ 
Volume 275,019       

(NASDAQ: SPRC) Delayed: 4.75 +0.18 (3.94%)
Previous Close $4.57    52 Week High $ 
Open $4.67    52 Week Low $ 
Day High $4.85    P/E N/A 
Day Low $4.39    EPS $ 
Volume 52,773       

(NASDAQ: SPRC) Delayed: 4.75 +0.18 (3.94%)
Previous Close $4.57    52 Week High $ 
Open $4.67    52 Week Low $ 
Day High $4.85    P/E N/A 
Day Low $4.39    EPS $ 
Volume 52,773